Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-139933
Filing Date
2020-12-28
Accepted
2020-12-28 20:00:55
Documents
1
Period of Report
2020-12-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2039398d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2039398d2_4.xml 4 13514
  Complete submission text file 0001104659-20-139933.txt   15886
Mailing Address 540 MADISON AVENUE, 38TH FLOOR NEW YORK NY 10022
Business Address
SAXENA PARAG (Reporting) CIK: 0001015823 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 201419797

Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address
Nayar Rahul (Reporting) CIK: 0001744923 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 201419798

Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 2127105220
Tenzing LLC (Reporting) CIK: 0001744957 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 201419796